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Madam, 
 
In the context of the excellent report of successful control of an outbreak of 
carbapenemase-producing Klebsiella pneumoniae in an Italian neonatal intensive care 
unit published in this journal (1), we wish to report the consequences of the first 
outbreak of KPC-producing Kliebsiella in Ireland and how, despite identification of 
operational factors associated with the incidence and best efforts towards rectifying 
those, our 410-bed hospital in the West of Ireland is failing to control endemic KPCs.  
Globally, there is recognition of the significant morbidity and mortality implications 
associated with emergence of carbapenemase-producing bacteria (2). The resulting 
vigilance has resulted in enhanced reporting of outbreaks, many being the first of their 
kind in specific countries (3), and descriptions of molecular studies to determine 
incidence and transfer of the carbapenemase-encoding blaKPC-harboring IncFIA 
plasmid between clonal variants (4). With indicative rates of carriage being circa 
20%, infection control specialists are reacting with novel techniques for 
microbiological detection, strategies for prevention of nosocomial transmission, and 
clinical microbiologists are facing therapeutic challenges related to limited, relatively 
unproven antimicrobial treatment options. 
At our hospital, between January and March 2011, there had been a reduction 
of 30% in cleaning staff and supervision in parallel with less than 50% overall 
compliance with hand hygiene protocols. It was to these factors that an outbreak of 9 
KPC cases were attributed. These occurred in high dependency (HDU: 4 cases: 
January & February) and intensive care (ICU: 4 cases: February) units and a 
dedicated surgical ward (4 cases: March). All strains involved were sensitive to 
gentamicin, colomycin & tigecycline, and were clonally related (using Pulsed-Field 
Gel Electrophoresis). PCR confirmed all carried blaKPC-2.  
As expected, outbreak management included identification of all affected 
areas and control of access; an attempt to determine the source; prevention of spread; 
communication of the risk to all staff, to public health agencies and all receiving 
hospitals in Ireland. As a consequence of the incidence, which was deemed 
successfully controlled, there was considerable and rapid investment in on-site 
molecular technology, enhanced hand hygiene training and surveillance, and 
introduction of a screening policy whereby all HDU and ICU transfers are isolated 
until determined to be negative for KPC carriage.  
Despite these measures, effective control has proved to be challenging. We 
have experienced simultaneous incidences of 7 cases in June 2012, 5 cases in January 
2014, and 4 cases in April 2014, with significant morbidity and mortality. In light of 
our inability to date prevent KPCs, we are debating the value of completing a study of 
local community carriage and revision of empirical first-line treatments, or even 
prophylaxis. 
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